Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current Status of Fibroblast Growth Factor Receptor-Targeted Therapies in Breast Cancer
Navid Sobhani, Anna Ianza, Alberto D’Angelo, et al.
Cells (2018) Vol. 7, Iss. 7, pp. 76-76
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

FGF/FGFR signaling in health and disease
Yangli Xie, Nan Su, Jing Yang, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 600
Fibroblast growth factor receptors in cancer: genetic alterations, diagnostics, therapeutic targets and mechanisms of resistance
Melanie A. Krook, Julie W. Reeser, Gabrielle Ernst, et al.
British Journal of Cancer (2020) Vol. 124, Iss. 5, pp. 880-892
Open Access | Times Cited: 256
Recent therapeutic trends and promising targets in triple negative breast cancer
Soo‐Yeon Hwang, Seojeong Park, Youngjoo Kwon
Pharmacology & Therapeutics (2019) Vol. 199, pp. 30-57
Open Access | Times Cited: 204
Endocrine Resistance in Hormone Receptor Positive Breast Cancer–From Mechanism to Therapy
Aradhana Rani, Justin Stebbing, Georgios Giamas, et al.
Frontiers in Endocrinology (2019) Vol. 10
Open Access | Times Cited: 189
Therapeutic advances of targeting receptor tyrosine kinases in cancer
Ciprian Tomuleasa, Adrian Bogdan Țigu, Raluca Munteanu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 25
The FGF/FGFR System in Breast Cancer: Oncogenic Features and Therapeutic Perspectives
Maria Francesca Santolla, Marcello Maggiolini
Cancers (2020) Vol. 12, Iss. 10, pp. 3029-3029
Open Access | Times Cited: 82
Genetic mutation and biological pathway prediction based on whole slide images in breast carcinoma using deep learning
Hui Qu, Mu Zhou, Zhennan Yan, et al.
npj Precision Oncology (2021) Vol. 5, Iss. 1
Open Access | Times Cited: 78
GPER Mediates a Feedforward FGF2/FGFR1 Paracrine Activation Coupling CAFs to Cancer Cells toward Breast Tumor Progression
Maria Francesca Santolla, Adele Vivacqua, Rosamaria Lappano, et al.
Cells (2019) Vol. 8, Iss. 3, pp. 223-223
Open Access | Times Cited: 56
The Fibroblast Growth Factor Receptors in Breast Cancer: from Oncogenesis to Better Treatments
Navid Sobhani, Chunmei Fan, Pedro O. Flores-Villanueva, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 6, pp. 2011-2011
Open Access | Times Cited: 55
ERK and Akt exhibit distinct signaling responses following stimulation by pro-angiogenic factors
Min Song, Stacey D. Finley
Cell Communication and Signaling (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 55
Targeting Aberrant FGFR Signaling to Overcome CDK4/6 Inhibitor Resistance in Breast Cancer
Navid Sobhani, Anne Fassl, Giuseppina Mondani, et al.
Cells (2021) Vol. 10, Iss. 2, pp. 293-293
Open Access | Times Cited: 39
Design, synthesis, and molecular docking of novel 2‐arylbenzothiazole multiangiokinase inhibitors targeting breast cancer
Heba T. Abdel‐Mohsen, Eman A. Abd El‐Meguid, Ahmed M. El Kerdawy, et al.
Archiv der Pharmazie (2020) Vol. 353, Iss. 4
Closed Access | Times Cited: 36
Fibroblast growth receptor 1 is regulated by G-quadruplex in metastatic breast cancer
Hang Lin, Muhammad Hassan Safdar, Sarah Washburn, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 4
Targeting Drugs Against Fibroblast Growth Factor(s)-Induced Cell Signaling
Shilpi Agrawal, Sanhita Maity, Zeina Alraawi, et al.
Current Drug Targets (2020) Vol. 22, Iss. 2, pp. 214-240
Closed Access | Times Cited: 28
Crosstalk between Tumor-Infiltrating Immune Cells and Cancer-Associated Fibroblasts in Tumor Growth and Immunosuppression of Breast Cancer
Jarupa Soongsathitanon, Pranisa Jamjuntra, Nuttavut Sumransub, et al.
Journal of Immunology Research (2021) Vol. 2021, pp. 1-15
Open Access | Times Cited: 24
Preparation and Characterization of an Engineered FGF1 Conjugated to 161Tb for Targeting of FGFRs
Linlin Song, Michał Kostas, Jon K. Laerdahl, et al.
ACS Omega (2025) Vol. 10, Iss. 6, pp. 5730-5743
Open Access
Case Series of Patients With FGFR1‐Related Pheochromocytoma and Paraganglioma With a Focus on Biochemical, Imaging Signatures and Treatment Options
Sakshi Jhawar, Abhishek Jha, Sara Talvacchio, et al.
Clinical Endocrinology (2025)
Open Access
MiR‐3116 sensitizes glioma cells to temozolomide by targeting FGFR1 and regulating the FGFR1/PI3K/AKT pathway
Shiqi Kong, Yingxiao Cao, Xin Li, et al.
Journal of Cellular and Molecular Medicine (2020) Vol. 24, Iss. 8, pp. 4677-4686
Open Access | Times Cited: 19
The cytotoxic conjugate of highly internalizing tetravalent antibody for targeting FGFR1-overproducing cancer cells
Marta Poźniak, Natalia Porębska, Mateusz Adam Krzyścik, et al.
Molecular Medicine (2021) Vol. 27, Iss. 1
Open Access | Times Cited: 16
Current Status of Fibroblast Growth Factor Receptors Targeted Therapies in Breast Cancer
Navid Sobhani, Anna Ianza, Alberto D’Angelo, et al.
(2018)
Open Access | Times Cited: 20
<p>Anticancer activity of 1, 25-(OH)<sub>2</sub>D<sub>3</sub> against human breast cancer cell lines by targeting Ras/MEK/ERK pathway</p>
Wei Zheng, Lin Cao, Linna Ouyang, et al.
OncoTargets and Therapy (2019) Vol. Volume 12, pp. 721-732
Open Access | Times Cited: 18
Catalytically inactive receptor tyrosine kinase PTK7 activates FGFR1 independent of FGF
Won‐Sik Shin, Hae Won Lee, Seung‐Taek Lee
The FASEB Journal (2019) Vol. 33, Iss. 11, pp. 12960-12971
Open Access | Times Cited: 17
Participation of MicroRNAs in the Treatment of Cancer with Phytochemicals
Seung Wan Son, Han Yeoung Lee, Sokviseth Moeng, et al.
Molecules (2020) Vol. 25, Iss. 20, pp. 4701-4701
Open Access | Times Cited: 16
Circular RNA circFGFR1 Functions as an Oncogene in Glioblastoma Cells through Sponging to hsa-miR-224-5p
Qian Zhang, Shan Chen, Yingwei Zhen, et al.
Journal of Immunology Research (2022) Vol. 2022, pp. 1-14
Open Access | Times Cited: 10
Overview of the clinical use of erdafitinib as a treatment option for the metastatic urothelial carcinoma: where do we stand
Alberto D’Angelo, Stefan Bagby, Ilaria Camilla Galli, et al.
Expert Review of Clinical Pharmacology (2020) Vol. 13, Iss. 10, pp. 1139-1146
Closed Access | Times Cited: 14
Page 1 - Next Page

Scroll to top